All News about Mydecine Innovations Group IncVia TheNewswire.com
![]() ![]() ![]()
Mydecine Provides Q4 2023 Business Update
October 26, 2023
Via GlobeNewswire
![]() ![]() Via Benzinga
![]() ![]()
Mydecine Announces Conditional Approval of CSE Listing
August 30, 2023
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Penticton Herald
Phone number: 250-492-4002
E-mail: csr@ok.bc.ca
Address: 186 Nanaimo Ave. W.
Penticton, BC V2A 1N4
© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.